Benefits firm to continue growth spurt, add 25 jobs
Nyhart Actuary & Employee Benefits plans to invest $840,000 to lease and equip an expansion of its Indianapolis headquarters, and already has started hiring.
Health Care & Insurance
Articles
Feds mull covering Alzheimer’s test that uses Lilly’s Amyvid
The $3,000 test for the first time accurately identifies the signature brain plaques of the debilitating disease.
CNO repurchases $50M in shares in second quarter
The Carmel-based insurer expects to repurchase $250 million to $300 million of securities this year.
St. Vincent Health eliminating about 865 jobs in Indiana
It was not clear how many workers were losing their jobs in the Indianapolis area. However, people familiar with the cuts said the reductions were heavy in the administrative ranks, and many of those jobs are on the city’s north side.
Answer on Indiana Medicaid plan could take some time
The head of the state Family and Social Services Administration said Tuesday that the federal government is expected to approve an extension of the Healthy Indiana Plan, but a request to use the plan for an Indiana Medicaid expansion could take much longer.
Lilly wins patent lawsuit on J&J Alzheimer’s research
A patent held by J&J’s Janssen Alzheimer Immunotherapy Research & Development unit isn’t valid, Judge Richard Arnold said in a ruling in London Tuesday.
Obamacare rebates total $22.6M in Indiana
Indiana consumers are set to receive rebates that are 59 percent larger this year as Obamacare continues to force health insurers to refund premiums that exceed actual medical claims by more than 20 percent.
WellPoint’s respite from criticism will be short-lived
With recent attention focused on hospital prices, WellPoint and its peers have been enjoying a nice break from their long-running status as Public Enemy No. 1 in the nation’s health care debate. They shouldn’t expect it to last.
WellPoint cap program saves Calpers big money
The nation’s largest pension fund worked with the Indianapolis-based health insurer to cut medical costs 19 percent by capping the price of some surgeries, in the latest sign payers are taking a tougher line against rising hospital claims.
Lilly’s experimental diabetes drug helps patients lose weight
Lilly’s drug, if approved, may be a significant competitor to Novo Nordisk A/S’s Victoza, which generated $1.64 billion in 2012.
Indiana tangles with shortage of rural doctors
The federal health care overhaul is expected to exacerbate problems regarding access to care in rural Indiana communities where is there is already a shortage of doctors and other health care providers.
WellPoint settles Los Angeles lawsuit for $6M
The city had alleged that WellPoint’s Anthem Blue Cross of California unit illegally dropped more than 6,000 policyholders from coverage.
Startup pitching app as money-saver for hospitals
The founder and CEO of Diagnotes Inc. thinks his company’s mobile app can help doctors run their office from their iPhones—just as many other professionals have been doing for years.
IT revolution coming to local health care
Local providers will increasingly look for help from IT firms like Indigo Biosystems Inc. and VoCare Inc. as part of a coming wave of health IT innovation that is likely to mirror the IT revolution that began 30 years ago.
Lilly’s Zyprexa injection probed by FDA after deaths
Eli Lilly and Co.’s injectable form of the antipsychotic Zyprexa is being investigated by U.S. regulators after two patients died three to four days after receiving the drug.
Drugmakers may face ‘pay for delay’ suits, high court rules
Drug companies like Eli Lilly and Co. can be sued for paying rivals to delay low-cost versions of popular medicines, the U.S. Supreme Court said in a decision that rewrites the rules governing the release of generic drugs.
Indiana agency sued over cuts to program for disabled
A federal lawsuit says Indiana's social services agency has made changes to Medicaid waiver programs that threaten to deprive thousands of developmentally disabled people of income they need to survive outside of institutions.
Lilly’s pipeline failures concern analysts
The failures raise pressure on Lilly’s experimental diabetes and cancer drugs to make it to market to offset looming patent expirations.
Medicare report a fresh threat to local hospital finances
A new recommendation from the Medicare Payment Advisory Commission, if enacted, would likely end one of the ways Indianapolis-area hospitals have generated healthy revenue from their recent spree of physician acquisitions.
Lilly to take over development of diabetes drug
Eli Lilly and Co. will pay Canadian drug developer Transition Therapeutics Inc. at least $7 million and up to as much as $247 million to take over the development of a potential diabetes treatment.